US Broker Ratings

Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth and Volatility in the Genomics Sector

As a prominent player in the genomics sector, Illumina, Inc. (NASDAQ: ILMN) has carved out a significant niche with its cutting-edge sequencing and array-based solutions. For..

Penumbra, Inc. (PEN) Stock Analysis: Exploring Growth Potential and Analyst Consensus for Investors

Penumbra, Inc. (NYSE: PEN), a leading player in the healthcare sector specializing in medical devices, has emerged as a noteworthy consideration for investors seeking exposure to..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring a 24.82% Potential Upside in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has emerged as a prominent player in the biotechnology sector, with its focus on innovative treatments for metabolic dysfunction-associated steatohepatitis (MASH)...

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with a 14.2% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company at the forefront of developing innovative treatments for B-cell mediated diseases, has captured the attention of investors with..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Biotechnology Pioneer with 12.40% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is increasingly capturing the attention of investors in the biotechnology sector. With its impressive portfolio of genetic medicines targeting diseases with..

Telix Pharmaceuticals Limited (TLX): Navigating a 105% Potential Upside with Innovative Radiopharmaceuticals

Telix Pharmaceuticals Limited (TLX) is carving a niche in the biopharmaceutical sector with its innovative approach to therapeutic and diagnostic radiopharmaceuticals. As a commercial-stage company, Telix..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unveiling a 33.51% Potential Upside in Biotechnology

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the biotechnology sector with its innovative approach to developing treatments for muscle-related diseases. The company’s singular focus on muscle..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 14.97% Upside Potential

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, stands as a compelling investment opportunity in the diagnostics and research industry. With a..

Corcept Therapeutics (CORT) Stock Analysis: Unveiling a Potential 11.16% Upside in Biotech

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has been capturing investor attention with its promising pipeline of medications targeting severe endocrinologic..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth with a 52.60% Revenue Surge

Oscar Health, Inc. (NYSE: OSCR) is making waves in the healthcare sector with its impressive revenue growth, capturing the attention of savvy investors. With the company..

Globus Medical, Inc. (GMED) Stock Analysis: 38.25% Potential Upside Beckons Investors in Healthcare Innovation

For investors eyeing the healthcare sector, Globus Medical, Inc. (NYSE: GMED) presents a compelling opportunity with a notable potential upside of 38.25%. Headquartered in Audubon, Pennsylvania,..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 16% Upside Potential in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) represents a compelling opportunity within the diagnostics & research industry, particularly for those interested in the burgeoning field of precision oncology...

Bruker Corporation (BRKR) Stock Analysis: Navigating the Intriguing Valuation Landscape in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly in the medical devices industry, is capturing investor attention with its innovative approach to..

Repligen Corporation (RGEN)

⚠️ No article content returned.

..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Evaluating a Potential 35% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a key player in the biotechnology sector, is garnering attention with its promising portfolio focused on rare neuroendocrine diseases. As a..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Biotech Giant with 41% Upside Potential

Sarepta Therapeutics, Inc. (SRPT), a leading player in the biotechnology sector, has been making waves in the healthcare industry, primarily through its cutting-edge RNA-targeted therapeutics and..

Quest Diagnostics (DGX) Stock Analysis: Deciphering Growth Potential Amid Strong Revenue Trajectory

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable entity in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of..

Investor Outlook: Bausch + Lomb Corporation (BLCO) Eyes 12% Upside Potential Amid Steady Growth

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors looking for..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a 5.13% Potential Upside and Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), based in Dublin, Ireland, stands out in the biotechnology sector with a market cap of $15.93 billion. As a key player..

ICON plc (ICLR) Stock Analysis: Investor Outlook on Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), headquartered in Dublin, Ireland, stands as a leading figure in the healthcare sector, particularly within the diagnostics and research industry. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds